Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Search results

From Bioblast
Results 1 – 21 of 39
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  • ...ubiquinone substrate, type B displace the ubisemiquinone intermediate, and type C are antagonists of the ubiquinol product.
    1 KB (158 words) - 13:55, 12 March 2021
  • |title=Prasun P (2020) Role of mitochondria in pathogenesis of type 2 diabetes mellitus. J Diabetes Metab Disord 19:2017-22. https://doi.org/10 ...e, mitochondria are important players in the pathogenesis of T2DM. In this article, pathogenesis of T2DM is examined from a mitochondrial perspective.
    1 KB (204 words) - 17:46, 22 October 2023
  • ...HC, Richman T, Tsoutsman T, Filipovska A, Semsarian C, Hool L (2016) The L-type Ca<sup>2+</sup> channel facilitates abnormal metabolic activity in the cTnI ...AC, resulting in a 'hypermetabolic' mitochondrial state. We propose that L-type Ca<sup>2+</sup> channel antagonists such as diltiazem may be effective in r
    4 KB (517 words) - 17:11, 7 November 2016
  • linked with the etiology of type 2 diabetes (T2D) and is lipid accumulation—the subject of this article.
    1 KB (167 words) - 12:12, 14 December 2015
  • ...g on insulin-mediated skeletal muscle glucose homeostasis in patients with type 2 diabetes. Acta Physiol (Oxf) 226:e13245. Ten males with type 2 diabetes mellitus (T2DM) and ten matched healthy subjects performed 2 wee
    3 KB (384 words) - 12:52, 9 August 2019
  • ...nd intermyofibrillar pools, since they are physically interconnected. This article is protected by copyright. All rights reserved.
    3 KB (352 words) - 15:46, 5 March 2019
  • ...altered regulation of fatty acid metabolism and oxidative stress status in type 2 diabetic Asian Indians. J Diabetes 12:542-55. |abstract=The cardiovascular complications associated with type 2 diabetes mellitus could be attributed to changes in myocardial mitochondr
    3 KB (381 words) - 16:54, 1 July 2020
  • ...TH reported in patients with THD, were characterized and compared to wild-type (wt)-TH with regards to ''in vitro'' solubility, thermal stability and kine In Article 1 we demonstrated the utility of a new oxygraphic assay to study the functi
    6 KB (826 words) - 13:27, 9 November 2017
  • ...ial oxidative phosphorylation is normal in obese patients with and without type 2 diabetes. J Physiol 594:4351-8. |abstract=Obese patients with (T2DM) and without (OB) type 2 diabetes are characterized by high hepatic lipid content and hepatic insu
    2 KB (332 words) - 15:47, 5 March 2019
  • ...ying-back pathology such as Friedreich ataxia, Charcot-Marie-Tooth disease type 2 and human immunodeficiency virus-associated distal-symmetric neuropathy.
    3 KB (362 words) - 19:11, 1 April 2018
  • ...that skeletal muscle mitochondria are a critical pathological link between type 2 diabetes and PAD. Furthermore, therapeutically targeting mitochondria and © 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for p
    2 KB (350 words) - 15:53, 13 November 2017
  • ...Miyamoto S, Moustaid-Moussa N, Festuccia WT (2019) Fish oil protects wild type and uncoupling protein 1 deficient mice from obesity and glucose intoleranc ...diposity and glucose intolerance and increasing energy expenditure in wild type and UCP1-deficient mice without recruiting other thermogenic processes in i
    3 KB (368 words) - 12:07, 9 August 2019
  • ...s and maturation during the intra erythrocyte cell cycle progression. This article is protected by copyright. All rights reserved.
    3 KB (406 words) - 00:55, 10 February 2020
  • ...in streptozotocin (STZ)-treated mice, an insulin-deficient mouse model of type 1 diabetes. BEZ treatment of STZ mice significantly suppressed the hepatic © 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for p
    3 KB (424 words) - 15:29, 9 November 2016
  • ...ablished health outcomes associated with chronic metabolic diseases (e.g., type II diabetes mellitus) is that the ability of skeletal muscle to maintain co <small>This article is protected by copyright. All rights reserved.</small>
    2 KB (280 words) - 15:19, 15 October 2019
  • ...associated with loss of mitochondrial function. A video abstract for this article is available at https://youtu.be/fs1G-QRo6xI.
    2 KB (255 words) - 10:25, 1 April 2019
  • ...erits further investigation as a supplement for treatment or prevention of type 2 diabetes in humans. © 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for p
    2 KB (346 words) - 10:35, 8 November 2016
  • ...efine the [[Electron-transfer-pathway state]]s. The [[N-pathway control |N-type substrates]] are listed in parentheses, independent of the sequence of titr » [[#Categorization of SUIT protocols: ETS pathway control states |'''MiPNet article''']]
    5 KB (673 words) - 16:25, 3 June 2020
  • ...induced renal medullary tissue hypoxia in an animal model of insulinopenic type 1 diabetes. The results suggest that the mechanistic pathway to attenuate t <small>This article is protected by copyright. All rights reserved.</small>
    2 KB (316 words) - 04:22, 12 February 2020
  • ...ed metabolic disorders such as diabetes and dyslipidemia of ZDF rats. This article is protected by copyright. All rights reserved.
    3 KB (400 words) - 08:04, 21 February 2020

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)